Knuff & Co’s Allergan plc AGN Stock Holding History

Knuff & Co’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-95	Closed	-$13K	–	149
2018 Q4	$13K	Buy	+95	New	+$15.6K	0.01%	102

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Knuff & Co's AGN Position: Q1 2019 in Review

Knuff & Co sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 95 shares — an estimated $13K sold.

Knuff & Co first reported a position in AGN in Q4 2018 and held it in 1 quarter. The position peaked at $13K in Q4 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

Knuff & Co reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
Knuff & Co sold 95 Allergan plc shares in Q1 2019, an estimated $13K.
Knuff & Co first reported a position in Allergan plc in Q4 2018 and held it in 1 quarter.
Knuff & Co's Allergan plc position peaked at $13K in Q4 2018.
991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Knuff & Co's 13F filing for Q1 2019, filed 8 May 2019.